Reassessment of Subacute MPTP-treated Mice as Animal Model of Parkinson's Disease

Acta Pharmacologica Sinica - United Kingdom
doi 10.1038/aps.2017.49
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Use of the MPTP-Treated Mouse as an Animal Model of Parkinsonism

Canadian Journal of Neurological Sciences
MedicineNeurology
1987English

Selegiline Rescues Gait Deficits and the Loss of Dopaminergic Neurons in a Subacute MPTP Mouse Model of Parkinson's Disease

International Journal of Molecular Medicine
MedicineGenetics
2013English

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Journal of Visualized Experiments
ImmunologyMolecular BiologyBiochemistryMicrobiology Chemical EngineeringNeuroscienceGenetics
2019English

Animal Models of Parkinson's Disease

2006English

Loss of Enteric Dopaminergic Neurons and Associated Changes in Colon Motility in an MPTP Mouse Model of Parkinson's Disease

Experimental Neurology
Developmental NeuroscienceNeurology
2007English

The PPARγ Agonist Pioglitazone Is Effective in the MPTP Mouse Model of Parkinson's Disease Through Inhibition of Monoamine Oxidase B

British Journal of Pharmacology
Pharmacology
2008English

Mitochondrial Dysfunction in Genetic Animal Models of Parkinson's Disease

Antioxidants and Redox Signaling
Cell BiologyMolecular BiologyBiochemistryClinical BiochemistryMedicinePhysiology
2012English

Animal Models of the Non-Motor Features of Parkinson's Disease

Neurobiology of Disease
Neurology
2012English

An AAV-derived Apaf-1 Dominant Negative Inhibitor Prevents MPTP Toxicity as Antiapoptotic Gene Therapy for Parkinson's Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy